about
Transcription factors bind thousands of active and inactive regions in the Drosophila blastodermLoss of NAPRT1 expression by tumor-specific promoter methylation provides a novel predictive biomarker for NAMPT inhibitors.High-resolution mapping of meiotic crossovers and non-crossovers in yeast.TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancerDiverse somatic mutation patterns and pathway alterations in human cancersAtezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoterAtezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trialAlternative epigenetic chromatin states of polycomb target genesIndependent filtering increases detection power for high-throughput experimentsHuman biosample authentication using the high-throughput, cost-effective SNPtrace(TM) system.Genome-wide survey of post-meiotic segregation during yeast recombination.Enhancing the antitumor efficacy of a cell-surface death ligand by covalent membrane display.Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.Array-based genotyping in S.cerevisiae using semi-supervised clustering.Functional screening implicates miR-371-3p and peroxiredoxin 6 in reversible tolerance to cancer drugs.Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial.A comprehensive transcriptional portrait of human cancer cell lines.High-throughput detection of clinically relevant mutations in archived tumor samples by multiplexed PCR and next-generation sequencing.Reproducible pharmacogenomic profiling of cancer cell line panels.A resource for cell line authentication, annotation and quality control.Comparative oncogenomics identifies PSMB4 and SHMT2 as potential cancer driver genes.A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation.DNA methylation profiling defines clinically relevant biological subsets of non-small cell lung cancer.Genome-wide analysis of Polycomb targets in Drosophila melanogaster.SpeCond: a method to detect condition-specific gene expression.Genome-wide allele- and strand-specific expression profiling.Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma.miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.Querying genomic databases: refining the connectivity map.Enzymic, phylogenetic, and structural characterization of the unusual papain-like protease domain of Plasmodium falciparum SERA5.The serine repeat antigen (SERA) gene family phylogeny in Plasmodium: the impact of GC content and reconciliation of gene and species trees.SpeCond: a method to detect condition-specific gene expression.Reply to Talloen et al.: Independent filtering is a generic approach that needs domain specific adaptation.Correction: Transcription Factors Bind Thousands of Active and Inactive Regions in the Drosophila Blastoderm.High-Throughput and Sensitive Quantification of Circulating Tumor DNA by Microfluidic-Based Multiplex PCR and Next-Generation Sequencing.Reply to T.J. Kruser et al.TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.Discovery and development of DNA methylation-based biomarkers for lung cancerSingle-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy
P50
Q21563555-B885E936-A64A-4643-8376-8165A66DE949Q27852577-A7E58E7E-8F4B-4CC3-B75E-0781ABC19AA7Q27938210-D4D2C622-E436-4207-AC10-A7E9DF4D38CDQ28117296-60665868-FEB9-46ED-8FB4-8035D8016C84Q29619825-A51BEDE6-BE67-4210-BA1E-05ED02BF1119Q30275266-480F5C39-2BB2-4C77-B47A-9040DBD3CE46Q30276647-EAFF8733-80C3-40E1-8F1B-6DE551EB2028Q30277192-0E0ECCF6-606C-4830-854D-C551A81524A4Q33523037-73549CAC-1478-4F82-9C42-4A9E3113EBDBQ34006510-1712AC5E-7A82-442B-A1A4-62F9EB4D625CQ35122895-13A126C4-EF18-4A03-B889-034E351ED3B4Q35557763-52A6CCFE-288D-4759-A906-D73D61830F0CQ35590091-DA7D96F1-A8AE-4AB8-B6D0-43BF788A2B3BQ36568988-97C245A8-AECA-4C05-AC3A-31B1C7A36813Q37153253-B790F315-6C89-4BDB-87F2-E8282FC1160DQ37156891-AABBF526-E278-4651-8C43-5D1EA9C4A63BQ37240846-C9B68CE0-C7F3-4E5D-9183-ED9C3C481411Q37854720-53009092-D2F5-46A7-9C7E-0B7AD4BF51F7Q38392770-BD6C9CB5-AE6C-4B5F-8EF0-BA91E2BEA4BFQ38770137-B413D025-EEE5-4229-9EAE-C70487B240FDQ38886793-A8BCCB0E-A0A1-4614-A17A-47844E4C024AQ39001985-4F1393D6-FA17-4774-9349-866C546916BCQ39180736-A01D5268-14C6-40A3-8230-BF47568E13F0Q39409491-37F920FE-5836-4CC9-8B23-8E32532B6A54Q40274308-165AE3F6-3FF6-4007-B3B9-BDC83C4E898CQ42131484-C8F66E05-61B1-438D-AEAD-DDA77388E3ACQ42225375-60C3F76C-2279-4D6E-87AC-042D8CCC8AC1Q42474003-F2550AE0-49CF-4BCE-90D5-461A391C728AQ42493425-EA6965FE-F5D0-4273-A3C1-3DBE2AAA4A0CQ43966937-D21B1114-331B-43CE-BE57-C2F53058473DQ44588572-9AA7C358-8BBA-477E-A857-A0EE3AF9CC6DQ45015235-6EE74729-3BC5-43F9-8EFF-600B5288C955Q45748678-3A6659DC-E12C-4037-BD48-38FE09019492Q45764316-71A437A3-1566-4424-90FE-AFE4CDF12A82Q45769126-F768A834-2EC6-431C-8D34-33101D037DCEQ46215686-C022A7EF-6ADF-4BF0-A43B-273262F47390Q46217382-7531612A-3FD8-4C14-A791-EFEA08EEAD33Q50001757-77CC7BB9-5AD0-4D27-BA12-480A6E263775Q87378872-47BB814A-34DC-420B-849D-60C6E9965291Q91172462-1C489A1D-8B6E-4ED9-95D3-E11F96DF42B0
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Richard Bourgon
@ast
Richard Bourgon
@en
Richard Bourgon
@es
Richard Bourgon
@nl
Richard Bourgon
@sl
type
label
Richard Bourgon
@ast
Richard Bourgon
@en
Richard Bourgon
@es
Richard Bourgon
@nl
Richard Bourgon
@sl
prefLabel
Richard Bourgon
@ast
Richard Bourgon
@en
Richard Bourgon
@es
Richard Bourgon
@nl
Richard Bourgon
@sl
P106
P1153
6505764442
P21
P31
P496
0000-0002-5890-4374